Met Life Investment Management, LLC Forte Biosciences, Inc. Transaction History

Met Life Investment Management, LLC

$17.1 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $13,533 - $167,655	-4,572 Closed	0 $0
Q2 2021 May 17, 2024	BUY	$31.5 - $42.5 $144,018 - $194,310	4,572 New	4,572 $153,000
Q2 2021 Jun 21, 2023	BUY	$31.5 - $42.5 $144,018 - $194,310	4,572 New	4,572 $153,000
Q2 2021 Mar 22, 2023	BUY	$31.5 - $42.5 $144,018 - $194,310	4,572 New	4,572 $153,000
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $144,018 - $194,310	4,572 New	4,572 $154,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$3.19 Million
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $371M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.